[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fDXGQxuzYCrTitNlZZ2XWCA6dQc3U-hSi-98aQZDJSM4":8,"$fubl6h5o9bFahYgHvd5-Qkn8ifqULvZjzG-DPbQA4FSI":53,"$fsRzNrmg8I-OK550vdanxyBmbJe_mJq1BmxeVSnRI2qs":57},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":52},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":6,"postsTitle":18,"materialTotal":19,"videoTotal":20,"isConcern":7,"title":21,"coverVertical":22,"coverAcross":23,"content":24,"description":25,"views":26,"likes":20,"isThumbsUp":7,"isCollection":7,"collections":20,"createTime":27,"seoTitle":21,"seoKeywords":28,"seoDescription":29,"shelvesTime":30,"version":31,"menus":32,"menuId":34,"type":19,"quality":51,"commentCount":20,"isComment":19},75911,871349,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","王艳丽","山西省肿瘤医院","住院医师",1,0,"弥漫大B细胞淋巴瘤：识别、诊断与治疗的实用指南","","https://ystcdn.venuertc.com/venue/AI/07aa54c9-abde-41fc-90b6-8a27d1f2eed4.jpg","\u003Cdiv class=\"dlymphoma-guide-wrapper\">\n  \u003Ch1 id=\"material_title\" class=\"dlymphoma-main-title\">弥漫大B细胞淋巴瘤：识别、诊断与治疗的实用指南\u003C/h1>\n  \n  \u003Csection class=\"dlymphoma-section dlymphoma-bg-1\">\n    \u003Ch2 class=\"dlymphoma-subtitle\">01 什么是弥漫大B细胞淋巴瘤？\u003C/h2>\n    \u003Cdiv class=\"dlymphoma-content\">\n      \u003Cp>\n        有时候，生活中突然多了一个看不见的小麻烦，让你在意外之间走进了医院。弥漫大B细胞淋巴瘤（DLBCL）就是这样的一种血液肿瘤。它属于淋巴瘤的一种类型，最常见于成年人。简单来讲，淋巴瘤是免疫系统中的B细胞变得异常，像被“操控”的卫士一样失去原有功能，反而不断增殖成团，形成肿块。DLBCL属于高侵袭性，也就是说它生长和扩散比其他一些淋巴瘤快。\u003Cbr>\n        按照细胞形态和基因特征，DLBCL可细分为多种亚型，但在实际生活里，大多数患者只需要关注医生给出的具体分类和治疗建议。它会影响全身淋巴结，有的也会累及身体其他脏器。不过，及时诊断和治疗能够大改善预后。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"dlymphoma-section dlymphoma-bg-2\">\n    \u003Ch2 class=\"dlymphoma-subtitle\">02 弥漫大B细胞淋巴瘤的常见症状有哪些？\u003C/h2>\n    \u003Cdiv class=\"dlymphoma-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">🟢\u003C/span> \u003Cb>肿大的淋巴结：\u003C/b>最突出的信号就是身体某处（常见在颈部、腋下或腹股沟）出现无痛、逐渐增大的包块。开始时可能只是微隆起，不会影响日常活动，但如果它持续变大，甚至摸起来很硬，这时就需要引起重视。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">🌡️\u003C/span> \u003Cb>持续发热、夜间出汗：\u003C/b>有些人可能以为是普通感冒，但反复发烧、晚上大量出汗，甚至夜里要换衣服，往不是简单的小毛病。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">💧\u003C/span> \u003Cb>体重明显减轻：\u003C/b>在没有刻意节食或运动的情况下，短时间内体重减轻超过10%，需要留心。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">😓\u003C/span> \u003Cb>疲乏、食欲下降：\u003C/b>经常觉得没力气或突然不想吃饭，这种持续的异常现象也是警示信号。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan style=\"color: #b59555;\">病例举例：\u003C/span>\n        有位58岁的男性患者，最初只是摸到脖子上有个小肿块，起初并不在意。但随着时间推移，肿块逐渐变大，并伴有夜间出汗和食欲减退。最终到医院检查诊断为弥漫大B细胞淋巴瘤。这个案例提醒我们，身体出现持续、明显的变化时，不要犹豫要及时就医。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"dlymphoma-section dlymphoma-bg-3\">\n    \u003Ch2 class=\"dlymphoma-subtitle\">03 弥漫大B细胞淋巴瘤的致病机制及风险因素是什么？\u003C/h2>\n    \u003Cdiv class=\"dlymphoma-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">🧬\u003C/span> \u003Cb>免疫系统异常：\u003C/b>当身体的免疫防线失调时，B细胞可能因基因突变或分化紊乱，发展成异常细胞。这些异常B细胞会失去正常功能，反而异常增殖，累及淋巴结及器官。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">🦠\u003C/span> \u003Cb>病毒感染：\u003C/b>一些病毒（如EB病毒、丙型肝炎病毒等）可提高淋巴瘤风险。例如，EB病毒会影响B细胞，可能促发淋巴细胞癌变。\u003Csup>[1]\u003C/sup>\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">👨‍👩‍👧‍👦\u003C/span> \u003Cb>遗传和年龄：\u003C/b>家族中曾有人患淋巴瘤，个人风险会略增。此外，DLBCL多见于50岁以上人群，这与自身免疫力变化有关。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">🧑‍⚕️\u003C/span> \u003Cb>其他风险：\u003C/b>放射暴露、自身免疫疾病患者（如系统性红斑狼疮）、长期免疫抑制者也更易发病。\u003Csup>[2]\u003C/sup>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        这些因素单独看并不会一定引发疾病，但多种因素叠加，可能让DLBCL“悄找上门”。不过具体到个人，仍以个体差异为主，整体发病率属于中等偏低（据统计，每10万人中大约有7人/年新发DLBCL）。\u003Csup>[3]\u003C/sup>\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"dlymphoma-section dlymphoma-bg-4\">\n    \u003Ch2 class=\"dlymphoma-subtitle\">04 如何准确诊断弥漫大B细胞淋巴瘤？\u003C/h2>\n    \u003Cdiv class=\"dlymphoma-content\">\n      \u003Cp>\n        诊断DLBCL往是一个系统的过程，并不是简单查个血就可以。医生会根据症状和体格检查初步判断，然后根据实际情况安排以下检查：\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">🔬\u003C/span> \u003Cb>淋巴结活检：\u003C/b>这是诊断的核心。通过微创取出一小块淋巴结或相关组织，进行病理学和免疫组化分析，明确是否是淋巴瘤，以及具体类型。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">🖥️\u003C/span> \u003Cb>影像学检查（CT、PET-CT）：\u003C/b>\n          显示肿瘤位置、大小及有无向身体其他部位扩散。PET-CT还可评估治疗后肿瘤是否消退。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">🩺\u003C/span> \u003Cb>骨髓检查：\u003C/b> 通过抽取骨髓样本，判断病情是否侵犯骨髓。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">🧪\u003C/span> \u003Cb>实验室检查：\u003C/b> 包括血常规、肝肾功能、乳酸脱氢酶（LDH）、β2-微球蛋白等，这些数值可辅助判定病情严重程度。\u003Csup>[4]\u003C/sup>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        整个过程中，患者可能需要配合多项检查。其实这些步骤虽然有些繁琐，但每一项都帮助医生更精确评估病情，为后续治疗做准备。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"dlymphoma-section dlymphoma-bg-5\">\n    \u003Ch2 class=\"dlymphoma-subtitle\">05 弥漫大B细胞淋巴瘤的治疗方法有哪些？\u003C/h2>\n    \u003Cdiv class=\"dlymphoma-content\">\n      \u003Cp>\n        对于DLBCL，现代医学已经有了比较成熟的应对方法，医生会根据具体情况选择并调整治疗方案。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">💉\u003C/span> \u003Cb>化疗：\u003C/b>最经典的是R-CHOP方案，包括利妥昔单抗（R）、环磷酰胺、阿霉素、长春新碱和泼尼松。按疗程给予，通常是每三周一次，总周期根据个体情况调整。\u003Csup>[5]\u003C/sup>\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">🎯\u003C/span> \u003Cb>靶向药物：\u003C/b>部分特殊亚型可以用布鲁顿酪氨酸激酶抑制剂等靶向治疗，能够精准“锁定”异常B细胞，减少对正常组织影响。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">🧬\u003C/span> \u003Cb>免疫治疗：\u003C/b> 如CAR-T细胞治疗（即将自身免疫细胞“升级”再输入体内），为部分复发难治患者带来新的希望。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">💊\u003C/span> \u003Cb>其他方式：\u003C/b>根据病情，还可能需放疗或干细胞移植等个性化选择。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        选择是什么方案，须结合年龄、身体状况和肿瘤分子特征综合考虑。医生团队会根据实际疗效调整流程。不同阶段的患者，治疗方案和反应也会有差异。不得不说，规范化治疗可以让许多DLBCL患者获得较高治愈率，早发现早治疗最重要。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"dlymphoma-section dlymphoma-bg-6\">\n    \u003Ch2 class=\"dlymphoma-subtitle\">06 如何进行弥漫大B细胞淋巴瘤的日常管理和预防？\u003C/h2>\n    \u003Cdiv class=\"dlymphoma-content\">\n      \u003Cp>\n        日常生活中，科学管理有助于患者身体恢复，同时能在一定程度上减少相关健康风险。以下这些方式简单实用，能支持身体免疫力，辅助疾病管理：\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">🥦\u003C/span> \u003Cb>新鲜蔬菜水果 + 提升维生素摄入 + 每天建议搭配多种颜色、尽量生吃或轻微蒸煮\u003C/b>\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">🍗\u003C/span> \u003Cb>优质蛋白质如鱼类、瘦肉、豆制品 + 修复组织 + 推荐每顿留出掌心大小\u003C/b>\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">🍚\u003C/span> \u003Cb>粗粮杂粮如糙米、燕麦 + 维持肠道功能 + 日常主食适当替换白米面\u003C/b>\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">🚶\u003C/span> \u003Cb>适量运动 + 保持免疫活力 + 每次30分钟轻松步行、每周3-5次\u003C/b>\n        \u003C/li>\n        \u003Cli>\n            \u003Cspan class=\"dlymphoma-emoji\">⚕️\u003C/span> \u003Cb>定期体检和专科随访 + 早期发现疾病变化 + 治疗恢复后每3-6个月复诊、视医生建议调整频率\u003C/b>\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dlymphoma-emoji\">😴\u003C/span> \u003Cb>高质量睡眠 + 身体修复 + 作息规律，保持7-8小时深度睡眠\u003C/b>\n        \u003C/li>\n        \u003Cli>\n            \u003Cspan class=\"dlymphoma-emoji\">🧑‍⚕️\u003C/span> \u003Cb>出现持续不明肿块、无原因发热或体重明显下降时及时就医，首选有血液科专业团队的医院为佳。\u003C/b>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        说起来，健康饮食和规律生活看似简单，却是支持血液系统长效运转的“秘诀”。日积月累，每一个坚持的小习惯，都有助于更好地恢复和管理身体。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"dlymphoma-section dlymphoma-bg-7\">\n    \u003Ch2 class=\"dlymphoma-subtitle\">结语\u003C/h2>\n    \u003Cdiv class=\"dlymphoma-content\">\n      \u003Cp>\n        日常生活里，免疫系统就像你身体里的守护队，偶有异常也不必惊慌。遇到类似弥漫大B细胞淋巴瘤这类少见而严重的问题，及时求助专业医生，配合科学管理，就能把健康风险降得更低。把握每个早发现和持续关注的机会，既是对自己健康最大的负责，也能让身边的人安心。最后，愿每个人都能更自如地面对健康小麻烦，也更安心地过好每一天。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"dlymphoma-section dlymphoma-bg-ref\">\n    \u003Ch2 class=\"dlymphoma-subtitle\">引用文献\u003C/h2>\n    \u003Cdiv class=\"dlymphoma-content\">\n      \u003Col>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:600;\">Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P.\u003C/span>\n          (2005). Global cancer statistics, 2002. \u003Ci>CA: A Cancer Journal for Clinicians\u003C/i>, 55(2), 74–108. https://doi.org/10.3322/canjclin.55.2.74\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:600;\">Swerdlow, S. H., Campo, E., Harris, N. L., et al.\u003C/span>\n          (2016). The 2016 revision of the World Health Organization classification of lymphoid neoplasms. \u003Ci>Blood\u003C/i>, 127(20), 2375-2390. https://doi.org/10.1182/blood-2016-01-643569\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:600;\">Smith, A., Howell, D., Patmore, R., et al.\u003C/span>\n          (2011). Incidence of hematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. \u003Ci>British Journal of Cancer\u003C/i>, 105(11), 1684–1692. https://doi.org/10.1038/bjc.2011.450\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:600;\">Coiffier, B., Thieblemont, C., Van Den Neste, E., et al.\u003C/span>\n          (2010). Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing R-CHOP to CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte. \u003Ci>Blood\u003C/i>, 116(12), 2040–2045. https://doi.org/10.1182/blood-2010-03-276246\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan style=\"font-weight:600;\">Sehn, L. H. & Salles, G.\u003C/span>\n          (2021). Diffuse Large B-Cell Lymphoma. \u003Ci>New England Journal of Medicine\u003C/i>, 384(9), 842-858. https://doi.org/10.1056/NEJMra2027612\n        \u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.dlymphoma-guide-wrapper {\n  font-family: \"PingFang SC\", \"Microsoft YaHei\", Arial, sans-serif;\n  color: #3a3347;\n  background: #fcfa;\n  margin: 0 auto;\n  padding: 32px 12% 40px 12%;\n  border-radius: 24px;\n  box-shadow: 0 4px 32px rgba(86,77,49,.1);\n  max-width: 950px;\n  min-width: 340px;\n  line-height: 2;\n}\n\n.dlymphoma-main-title {\n  font-size: 2.45em;\n  font-weight: bold;\n  margin: 0 0 40px 0;\n  color: #51666d;\n  letter-spacing: 1px;\n  text-align: center;\n}\n\n.dlymphoma-section {\n  margin-bottom: 38px;\n  border-radius: 16px;\n  padding: 30px 36px;\n  box-shadow: 0 3px 10px rgba(235,192,134,0.07);\n  background-repeat: no-repeat;\n  background-size: contain;\n}\n\n.dlymphoma-subtitle {\n  font-size: 1.35em;\n  font-weight: 600;\n  color: #af842d;\n  margin-bottom: 16px;\n  margin-top: 0;\n  text-shadow: 0 1px 1px #fffef8;\n  display: flex;\n  align-items: center;\n}\n\n.dlymphoma-content {\n  font-size: 1.1em;\n}\n\n.dlymphoma-emoji {\n  margin-right: 8px;\n  font-size: 1.19em;\n}\n\n.dlymphoma-bg-1 {\n    background: linear-gradient(110deg, #f6e2a4 0%, #f2ede2 100%);\n}\n.dlymphoma-bg-2 {\n    background: linear-gradient(114deg, #e4e8c5 0%, #fef6da 100%);\n}\n.dlymphoma-bg-3 {\n    background: linear-gradient(102deg, #d6dfe8 0%, #f8f1e3 80%);\n}\n.dlymphoma-bg-4 {\n    background: linear-gradient(116deg, #e7ede5 0%, #f7f7e2 100%);\n}\n.dlymphoma-bg-5 {\n    background: linear-gradient(118deg, #ffe6e3 0%, #f8f2df 80%);\n}\n.dlymphoma-bg-6 {\n    background: linear-gradient(113deg, #daf1e1 0%, #faf7e6 100%);\n}\n.dlymphoma-bg-7 {\n    background: linear-gradient(110deg, #fcf0dd 0%, #eeeadc 100%);\n}\n.dlymphoma-bg-ref {\n    background: #faf8f3;\n}\n\n.dlymphoma-content ul {\n  margin: 0 0 12px 10px;\n  padding: 0 0 0 8px;\n}\n\n.dlymphoma-content ul li {\n  margin: 8px 0 8px 0;\n  padding-left: 0;\n  list-style-type: none;\n  word-break: break-all;\n}\n\n.dlymphoma-content ol {\n  margin: 0 0 0 32px;\n}\n\n.dlymphoma-content sup {\n    font-size: 0.95em;\n    color: #b27e39;\n    vertical-align: top;\n}\n@media only screen and (max-width: 760px) {\n  .dlymphoma-guide-wrapper {\n    padding: 18px 2% 18px 2%;\n  }\n  .dlymphoma-section {\n    padding: 18px 6%;\n  }\n  .dlymphoma-main-title {\n    font-size: 1.28em;\n  }\n  .dlymphoma-content {\n    font-size: 1em;\n  }\n}\n\u003C/style>","\u003Cdiv class=\"dlymphoma-guide-wrapper\">\n  \u003Ch1 id=\"material_title\" class=\"dlymphoma-main-title\">弥漫大B细胞淋",565,"2025-12-09 01:51:36","弥漫大B细胞淋巴瘤, DLBCL, 淋巴瘤症状, 免疫系统, 癌症治疗, 疾病诊断","了解弥漫大B细胞淋巴瘤（DLBCL）的症状、诊断与治疗方法，掌握健康管理知识，为您和您的家人提供科学支持，提高生活质量。","2026-01-08 06:00:49",2,[33],{"menuId":34,"menuName":35,"parentId":20,"orderNum":31,"path":36,"component":37,"isFrame":38,"isCache":39,"menuType":40,"visible":19,"status":20,"createDept":6,"remark":22,"createTime":41,"children":42,"columnImage":43,"columnLogo":44,"uncheckedLogo":6,"checkedLogo":6,"isHot":19,"isHome":20,"forceLogin":20,"color":45,"seoTitle":46,"seoKeywords":47,"seoDescription":48,"contentNum":6,"promotionalPoster":49,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":50,"routerPath":36,"componentInfo":37},"1986713082609147906","健康科普","article","/article.html","1","0","T","2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":54,"success":52},{"pageNo":19,"pageSize":55,"result":56,"totalSize":20},10,[],{"code":9,"msg":10,"message":6,"data":58,"success":52},{"authors":59,"appraiseDimensionScoresVos":60},[],[]]